These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11833196)

  • 1. Panel rules against Canada on patent terms for pre-TRIPS patents.
    Elliott R
    Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):43, 45. PubMed ID: 11833196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canada loses appeal of WTO panel ruling on minimum patent terms.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2000; 5(4):25-6. PubMed ID: 11833160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canada ordered to implement WTO ruling against "stockpiling" of generic drugs.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2000; 5(4):27. PubMed ID: 11833161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. US files WTO complaints against Brazil over requirement for "local working" of patents.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2000; 5(4):28. PubMed ID: 11833162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed WTO ruling on generic drug development.
    Elliott R
    Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):38-42, 40-4. PubMed ID: 11833195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the World Trade Organization TRIPS agreement on the pharmaceutical industry in Thailand.
    Supakankunti S; Janjaroen WS; Tangphao O; Ratanawijitrasin S; Kraipornsak P; Pradithavanij P
    Bull World Health Organ; 2001; 79(5):461-70. PubMed ID: 11417042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
    Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
    Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intellectual property rights and the Canadian pharmaceutical marketplace: where do we go from here?
    Lexchin J
    Int J Health Serv; 2005; 35(2):237-56. PubMed ID: 15932005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Essential medicines and the TRIPS Agreement: collision between the right to health and intellectual property rights].
    Allard Soto R
    Salud Colect; 2015 Mar; 11(1):9-21. PubMed ID: 25853827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new patent regime and disease priorities in India.
    Gupta I; Guin P; Trivedi M
    Glob Public Health; 2013; 8(1):37-54. PubMed ID: 22845021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intellectual property rights and right of access to medicines].
    Velásquez G
    Med Trop (Mars); 2006 Dec; 66(6):526-8. PubMed ID: 17286013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical patents and some international trade issues: Canada, the United States, and NAFTA.
    Tancer RS
    Clin Ther; 1993; 15(6):1177-84; discussion 1120. PubMed ID: 8111813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WTO: US and Argentina settle dispute over patents and data protection.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):65. PubMed ID: 14743805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent implications in the pharmaceutical industry: Are static high prices leading to dynamic innovations?
    Pandey E; Paul SB
    Int J Risk Saf Med; 2019; 30(3):179-192. PubMed ID: 31450515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].
    Chaves GC; Oliveira MA; Hasenclever L; de Melo LM
    Cad Saude Publica; 2007 Feb; 23(2):257-67. PubMed ID: 17221075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bill C-30: who wins and who loses in Canada's pharmaceutical patent battles?
    Hollis A
    Expert Opin Ther Pat; 2018 Jan; 28(1):1-3. PubMed ID: 28974123
    [No Abstract]   [Full Text] [Related]  

  • 17. A proposal for measuring the degree of public health-sensitivity of patent legislation in the context of the WTO TRIPS Agreement.
    Chaves GC; Oliveira MA
    Bull World Health Organ; 2007 Jan; 85(1):49-56. PubMed ID: 17242758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canada files WTO complaint against EC.
    Can HIV AIDS Policy Law Rev; 2000; 5(4):29. PubMed ID: 11833163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian court upholds Glaxo's patent on AZT.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2001; 6(1-2):53-7. PubMed ID: 11837029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canada's laws on pharmaceutical intellectual property: the case for fundamental reform.
    Grootendorst P; Bouchard R; Hollis A
    CMAJ; 2012 Mar; 184(5):543-9. PubMed ID: 22065362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.